Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure

Ophthalmology

Volumn 117, Issue 11, 2010, Pages 2075-2079

  Liu, John H K ^a   Medeiros, Felipe A ^a   Slight, J Rigby ^a   Weinreb, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; QUINOXALINE DERIVATIVE;

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; MONOTHERAPY; OPEN ANGLE GLAUCOMA; PNEUMATONOMETER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SITTING; SLEEP WAKING CYCLE; SUPINE POSITION; TREATMENT DURATION; BLOOD PRESSURE; CIRCADIAN RHYTHM; COMPARATIVE STUDY; DRUG EFFECTS; GLAUCOMA, OPEN-ANGLE; MIDDLE AGED; OCULAR HYPERTENSION;

ADRENERGIC ALPHA-AGONISTS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CIRCADIAN RHYTHM; FEMALE; GLAUCOMA, OPEN-ANGLE; HEART RATE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PROSPECTIVE STUDIES; QUINOXALINES;

EID: 78049301553     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.03.026     Document Type: Article

References (31)

1. M.A. Kass, D.K. Heuer, E.J. Higginbotham Ocular Hypertension Treatment Study Group The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open angle glaucoma Arch Ophthalmol 120 2002 701 713
2. A. Heijl, M.C. Leske, B. Bengtsson Early Manifest Glaucoma Trial Group Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial Arch Ophthalmol 120 2002 1268 1279
3. R.N. Weinreb, and P.T. Khaw Primary open-angle glaucoma Lancet 363 2004 1711 1720
4. F.A. Medeiros, J. Brandt, and J. Liu IOP as a risk factor for glaucoma development and progression R.N. Weinreb, J.D. Brandt, D.F. Garway-Heath, F.A. Medeiros, Intraocular Pressure: Reports and Consensus Statements of the 4th Global AIGS Consensus Meeting on Intraocular Pressure 2007 Kugler The Hague, the Netherlands 59 74 WGA Consensus Series 4
5. N. Orzalesi, L. Rossetti, and T. Invernizzi Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension Invest Ophthalmol Vis Sci 41 2000 2566 2573
6. J.H. Liu, D.F. Kripke, and R.N. Weinreb Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure Am J Ophthalmol 138 2004 389 395
7. A.J. Sit, R.N. Weinreb, and J.G. Crowston Sustained effect of travoprost on diurnal and nocturnal intraocular pressure Am J Ophthalmol 141 2006 1131 1133
8. J.H. Liu, F.A. Medeiros, J.R. Slight, and R.N. Weinreb Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy Ophthalmology 116 2009 449 454
9. D.J. O'Connor, J.F. Martone, and A. Mead Additive intraocular pressure lowering effect of various medications with latanoprost Am J Ophthalmol 133 2002 836 837
10. N. Orzalesi, L. Rossetti, and A. Bottoli The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension Arch Ophthalmol 121 2003 453 457
11. A.G. Konstas, C.H. Karabatsas, and N. Lallos 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects Ophthalmology 112 2005 603 608 (Pubitemid 41108860)
12. R. van der Valk, C.A. Webers, and J.S. Schouten Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials Ophthalmology 112 2005 1177 1185
13. L. Quaranta, F. Gandolfo, and R. Turano Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma Invest Ophthalmol Vis Sci 47 2006 2917 2923
14. R.M. Feldman, A.P. Tanna, R.L. Gross Additivity Study Group Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004% Ophthalmology 114 2007 1248 1254
15. W.C. Stewart, A.G. Konstas, L.A. Nelson, and B. Kruft Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines Ophthalmology 115 2008 1117 1122
16. D.G. Day, and D.A. Hollander Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension Curr Med Res Opin 24 2008 1435 1442
17. C.B. Toris, M.L. Gleason, C.B. Camras, and M.E. Yablonski Effects of brimonidine on aqueous humor dynamics in human eyes Arch Ophthalmol 113 1995 1514 1517
18. L.I. Larsson Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination Arch Ophthalmol 119 2001 492 495
19. C.B. Toris, C.B. Camras, and M.E. Yablonski Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients Am J Ophthalmol 128 1999 8 14
20. A.J. Sit, C.B. Nau, and J.W. McLaren Circadian variation of aqueous dynamics in young healthy adults Invest Ophthalmol Vis Sci 49 2008 1473 1479
21. J.H. Liu, X. Zhang, D.F. Kripke, and R.N. Weinreb Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes Invest Ophthalmol Vis Sci 44 2003 1586 1590
22. J.H. Liu, D.F. Kripke, and M.D. Twa Twenty-four-hour pattern of intraocular pressure in the aging population Invest Ophthalmol Vis Sci 40 1999 2912 2917
23. J.H. Liu, P.A. Gokhale, and R.T. Loving Laboratory assessment of diurnal and nocturnal ocular perfusion pressures in humans J Ocul Pharmacol Ther 19 2003 291 297
24. M.E. Yablonski, T.J. Zimmerman, S.R. Waltman, and B. Becker A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics Exp Eye Res 27 1978 135 142 (Pubitemid 9004152)
25. C.J. Ingram, and R.F. Brubaker Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyes Am J Ophthalmol 128 1999 292 296
26. M. Aihara, J.D. Lindsey, and R.N. Weinreb Effect on diurnal intraocular pressure variation of eliminating the alpha-2 adrenergic receptor subtypes in the mouse Invest Ophthalmol Vis Sci 49 2008 929 933
27. J.E. Jumblatt, J.G. Liu, and G.T. North Alpha-2 adrenergic modulation of norepinephrine secretion in the perfused rabbit iris-ciliary body Curr Eye Res 6 1987 767 777
28. J.E. Topper, and R.F. Brubaker Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep Invest Ophthalmol Vis Sci 26 1985 1315 1319
29. T.J. Zimmerman, R. Harbin, M. Pett, and H.E. Kaufman Timolol and facility of outflow Invest Ophthalmol Vis Sci 16 1977 623 624 (Pubitemid 8146080)
30. R.L. Coakes, and R.F. Brubaker The mechanism of timolol in lowering intraocular pressure: in the normal eye Arch Ophthalmol 96 1978 2045 2048
31. Y.H. Ooi, D.J. Oh, and D.J. Rhee Analysis of alpha-2 adrenergic receptors and effect of brimonidine on matrix metalloproteinases and their inhibitors in human ciliary body Invest Ophthalmol Vis Sci 50 2009 4237 4243